Contents

Current Pharmaceutical Design, Volume 14 - Number 12

Editorial [Hot Topic: Drugs in Interventional Cardiology Executive Editor: Peter W. Radke ]

, 14(12): 1151

Peter W. Radke


DOI: 10.2174/138161208784246108




Pharmacological Strategies for Inhibition of Thrombin Activity

, 14(12): 1152 - 1175

S. Alban


DOI: 10.2174/138161208784246135




Anticoagulation in Patients with Heparin-Induced Thrombocytopenia undergoing Percutaneous Coronary Angiography and Interventions

, 14(12): 1176 - 1185

Alexander Joost, Volkhard Kurowski and Peter W. Radke


DOI: 10.2174/138161208784246126




Factor Xa Inactivation in Acute Coronary Syndrome

, 14(12): 1186 - 1190

Melanie Barantke and Hendrik Bonnemeier


DOI: 10.2174/138161208784246117




Safety and Efficacy of Bivalirudin in Acute Coronary Syndromes

, 14(12): 1191 - 1196

F. Hartmann


DOI: 10.2174/138161208784246081




Pharmacoeconomics of Anticoagulants in Acute Coronary Syndrome and Percutaneous Coronary Intervention

, 14(12): 1197 - 1204

S. A. Huston and D. Hawkins


DOI: 10.2174/138161208784246162




Bridging Innate Immunity and Myocardial Ischemia/Reperfusion Injury: The Search for Therapeutic Targets

, 14(12): 1205 - 1216

Fatih Arslan, Dominique P.V. de Kleijn, Leo Timmers, Pieter A. Doevendans and Gerard Pasterkamp


DOI: 10.2174/138161208784246090




The Blockade of IL-6 Signaling in Rational Drug Design

, 14(12): 1217 - 1224

Yasuo Adachi, Naoko Yoshio-Hoshino and Norihiro Nishimoto


DOI: 10.2174/138161208784246072




Adipose Tissue Macrophages, Low Grade Inflammation and Insulin Resistance in Human Obesity

, 14(12): 1225 - 1230

Leonie K. Heilbronn and Lesley V. Campbell


DOI: 10.2174/138161208784246153




Structure-Based Rationale for Interleukin 5 Receptor Antagonism

, 14(12): 1231 - 1239

Tetsuya Ishino, Adrian E. Harrington, Hosahudya Gopi and Irwin Chaiken


DOI: 10.2174/138161208784246144




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science